Dasm Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Kalyan, Maharashtra, India, established in 2019.
2019 Kalyan, Maharashtra, India Struck Off
Last Updated:
Access Report
About Dasm Pharmaceuticals Private Limited

Dasm Pharmaceuticals Private Limited, a struck off private limited company, was established on 01 November 2019 in Kalyan, Maharashtra, India. Engaging in specialty within the trading sector, it holds CIN: U51909MH2019PTC332439. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Deepak Dnyandeo Bende (Director), Abhishek Ashok Patil (Director). Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at Shop No 9, Ground Floor, Vaishali Building, Mohane Road, Kalyan Dombivali (M Corp),, Shahad, Kalyan, Maharashtra, 421301.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909MH2019PTC332439

  • Registration Number

    332439

  • Incorporation Date

    01 November 2019

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 7 Months
  • Last Filing with ROC 31 Mar 2020
Company report

Dasm Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Dasm Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Dasm Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Deepak Dnyandeo Bende Director 01 Nov 2019 Current
Abhishek Ashok Patil Director 01 Nov 2019 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Dasm Pharmaceuticals.

Dasm Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Dasm Pharmaceuticals revenue growth over time
Dasm Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Dasm Pharmaceuticals?

Unlock access to Dasm Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Dasm Pharmaceuticals?

Unlock and access historical data on people associated with Dasm Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Dasm Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dasm Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Dasm Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Dasm Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Dasm Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Deepak Dnyandeo Bende was appointed as a Director was appointed as a Director on 01 Nov 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.

  • Director Appointment

    Abhishek Ashok Patil was appointed as a Director was appointed as a Director on 01 Nov 2019 & has been associated with this company since 6 years 7 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Dasm Pharmaceuticals Private Limited was registered on 01 Nov 2019 with Roc Mumbai & aged 6 years 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Dasm Pharmaceuticals Private Limited?

The CIN of Dasm Pharmaceuticals Private Limited is U51909MH2019PTC332439.

Where is Dasm Pharmaceuticals Private Limited headquartered?

Dasm Pharmaceuticals Private Limited is headquartered at Shop No 9, Ground Floor, Vaishali Building, Mohane Road, Kalyan Dombivali (M Corp),, Shahad, Kalyan, Maharashtra, 421301.

When was Dasm Pharmaceuticals Private Limited incorporated?

Dasm Pharmaceuticals Private Limited was incorporated on 01 November 2019.

Who are the current directors of Dasm Pharmaceuticals Private Limited?

The current directors of Dasm Pharmaceuticals Private Limited are

What is the primary industry of Dasm Pharmaceuticals Private Limited?

The primary industry of Dasm Pharmaceuticals Private Limited is Trading.

Is Dasm Pharmaceuticals Private Limited a listed company?

Dasm Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Dasm Pharmaceuticals Private Limited?

The authorized capital of Dasm Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available